Consensus PharmaResearch Co., Ltd.

Equities

A214450

KR7214450009

End-of-day quote Korea S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
1,40,800 ^KRW	+3.68%		+10.34%	+28.58%

2023	PharmaResearch Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2021	PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd.	CI

Evolution of the average Target Price on PharmaResearch Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

c63fa5821d361f4.biEAjq63SDLxKNIndu-xObuu0ZyDm5tPTZG5iBIxNdc.BFJwtvzmZV7HEahLPd77DYzNgMOw_qMoCtDWzFFpV6IFRHrq2YAkZ4R_oQ~80749fa8d408d310024f10e2544f3e74

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,35,800 KRW

Average target price

1,75,000 KRW

Spread / Average Target

+28.87%

High Price Target

1,90,000 KRW

Spread / Highest target

+39.91%

Low Price Target

1,60,000 KRW

Spread / Lowest Target

+17.82%

Consensus detail

Consensus revision (last 18 months)

Ratings for PharmaResearch Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar